locktore.blogg.se - Foresight diagnostics

#FORESIGHT DIAGNOSTICS PROFESSIONAL#

In the first transaction on 5 October, he offloaded 105,984 shares for 291.38 US cents each, valuing the sale at $308,816.18. The firm said Dr James ‘Spike’ Willcocks made the sales across two transactions on 5 and 6 October, both on the US OTC market. The global Dry Eye Disease Diagnostic Devices market size is projected to reach multi million by 2028, in comparision to 2021, at unexpected CAGR during 2022-2028 (Ask for Sample Report). 2020 ( 2 years old in 2022 ) Company Focus.

They cover business area such as developer, cancer, healthcare professional, diagnosis, early small tumor, patient. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes. Foresight Diagnostics is Diagnostic Equipment in United States that focus on cancer type business.Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds.Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so.

#FORESIGHT DIAGNOSTICS PROFESSIONAL#

Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body.

Dr Aliyu was shocked by the growing number of Nigerians travelling abroad in search of better healthcare services, which is not unconnected to the dilapidated nature of the healthcare facilities in Nigeria.

Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services Foresight Healthcare was founded in 2016 by Dr Shamsuddeen Aliyu.

Obtains access to the information in a personal capacity.

I am a private investor* I am not a private investor *A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: